Mesothelioma, Secondary cancers
Open
Phase 2
This trial is looking at a drug called volrustomig for mesothelioma of the lung.
It is for people:
who are having their first treatment for mesothelioma of the lung and
whose mesothelioma has spread and it isn’t possible to remove it with surgery
Volrustomig is pronounced vol-rus-to-mig. It is also called MEDI5752.
Recruitment start: 26 April 2026
Recruitment end: 31 March 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Philip Earwaker
AstraZeneca
Last reviewed: 27 Jul 2026
CRUK internal database number: 20162
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
